Skip to content
Login

Concepts (22)

Non-communicable diseases (NCDs) pose a rising health burden in India, driven by lifestyle changes, necessitating multi-sectoral policy interventions for prevention and management.

Definition

Non-Communicable Diseases (NCDs), often referred to as chronic diseases, are medical conditions or diseases that are non-infectious and non-transmissible among people. They are typically of long duration and result from a combination of genetic, physiological, environmental, and lifestyle factors. Lifestyle diseases are a significant subset of NCDs, directly linked to daily habits such as diet, physical activity, and substance use. Major NCDs include cardiovascular diseases (CVDs), cancers, chronic respiratory diseases, and diabetes mellitus.

Key Facts

  • India's Double Burden: India is undergoing a complex epidemiological transition, as described by Omran A. (1971), where it faces a 'double burden' of disease. Persistent communicable diseases (CDs) like tuberculosis and vector-borne infections coexist with a rapidly rising incidence of NCDs (echap11.pdf, 11.42). Life expectancy at birth in India increased from 49.7 years in 1973 to 70.3 years in 2023, contributing to the rise of degenerative diseases (echap11.pdf).
  • Leading Causes of Mortality: NCDs now account for a substantial proportion of deaths. As per the SRS-Cause of Death in India Report for 2021-23, Cardiovascular diseases have been the leading cause of death for both men and women since 2004-06, with a higher proportion in males. Other major NCD causes include diabetes mellitus and malignant and other neoplasms (cancers) (echap11.pdf, 11.42, 11.43).
  • Rising Obesity: Obesity is a major public health challenge, affecting both urban and rural populations due to unhealthy diets, sedentary lifestyles, and increased consumption of ultra-processed foods (UPFs). It significantly increases the risk of NCDs like diabetes, heart disease, and hypertension (echap11.pdf, 11.44).
  • Gender Disparities: Men exhibit higher all-cause and cardiovascular mortality rates. However, women may experience worse prognosis and higher case fatality rates after acute cardiovascular events, potentially due to delayed diagnosis or under-treatment. A higher proportion of ill-defined causes of death in women suggests a need for improved diagnostic accuracy and healthcare utilisation among females (echap11.pdf, 11.42, 11.43).

Mechanism/Framework

NCDs develop through complex interactions. Genetic predispositions (e.g., for certain cancers or type 2 diabetes) can increase susceptibility, but lifestyle factors often act as triggers or accelerators. Unhealthy diets (high in salt, sugar, unhealthy fats, UPFs), lack of physical activity, tobacco use, and harmful alcohol consumption are primary behavioural risk factors. These lead to metabolic changes such as elevated blood pressure, increased blood glucose, elevated blood lipids, and obesity, which are intermediate risk factors for major NCDs. Environmental factors like air pollution also contribute to chronic respiratory and cardiovascular diseases.

Exam Angle

For Prelims, focus on definitions, examples of NCDs, key statistics (e.g., leading causes of death, life expectancy trends), and major risk factors. For Mains, the emphasis shifts to analytical understanding: the socio-economic determinants of NCDs, their impact on India's demographic dividend, policy responses (e.g., National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke - NPCDCS), challenges in implementation, and cross-sectoral linkages (health, economy, governance, ethics). Understanding India's unique 'double burden' and regional disparities (e.g., Kerala's health profile vs. other states, echap11.pdf, 11.41) is crucial for a nuanced answer.

scitech-diagram-NCD-progression

chart-NCD-mortality-trends-India-2004-2023

Analysis

India's battle against NCDs is a critical development challenge, not merely a health issue. The rapid rise in NCDs, alongside persistent communicable diseases, threatens to undermine the gains made in public health and derail economic progress. This 'double burden' is exacerbated by significant regional and socioeconomic disparities (echap11.pdf, 11.41). States like Kerala exhibit health profiles akin to developed nations, dominated by degenerative diseases, while others still grapple with malnutrition and infectious disease outbreaks. This highlights the uneven pace of epidemiological transition across the country.

The socio-economic determinants of NCDs are profound. Rapid urbanisation, coupled with changing dietary patterns towards ultra-processed foods (UPFs) and increasingly sedentary lifestyles, fuels the NCD epidemic (echap11.pdf, 11.44). Poverty often limits access to healthy food options and healthcare, while also exposing populations to environmental risks. The economic impact is substantial, including lost productivity due to premature mortality and morbidity, and increased healthcare expenditure, which can push families into poverty.

Policy challenges include a fragmented healthcare system, insufficient focus on preventive care, and inadequate public health infrastructure. While national nutrition programmes play a vital role, successful on-the-ground implementation largely depends on state-level innovations and effective governance (echap11.pdf, 11.56). Addressing NCDs requires a multi-sectoral approach involving health, agriculture, urban planning, education, and finance ministries.

The gender dimension is also critical. While men show higher overall NCD mortality, women often face delayed diagnosis and worse prognosis for conditions like cardiovascular diseases, pointing to systemic biases in healthcare access and treatment (echap11.pdf, 11.42, 11.43). The higher proportion of 'ill-defined' causes of death in women further underscores the need for improved diagnostic accuracy and healthcare utilisation for females.

Nutritional reforms are paramount. The ICMR-National Institute of Nutrition Report 2020 and subsequent guidelines emphasize increasing intake of vegetables and legumes, and reducing consumption of salt, fat, and sugar. Promoting locally grown and traditional foods, and leveraging social media for awareness generation, are crucial strategies (echap11.pdf, 11.62).

Comparison Table

FeatureNon-Communicable Diseases (NCDs)Communicable Diseases (CDs)
TransmissionNon-infectious, not transmissible from person to personInfectious, transmissible (e.g., bacterial, viral, parasitic)
DurationTypically long-term, chronicAcute or chronic, but often with distinct infectious phases
Primary CausesLifestyle (diet, activity, substance use), genetics, environmentPathogens (bacteria, viruses, parasites, fungi)
ExamplesCVDs, diabetes, cancers, chronic respiratory diseases, hypertensionTuberculosis, malaria, dengue, HIV/AIDS, COVID-19
India's BurdenRapidly rising, leading cause of mortality (e.g., CVDs)Persistent, but mortality declining; coexists with NCDs ('double burden')
InterventionsLifestyle modification, screening, long-term management, policyVaccination, antibiotics, vector control, sanitation, isolation
FeatureRural NCD BurdenUrban NCD Burden
PrevalenceHistorically lower, but rapidly increasing due to lifestyle changesHigher prevalence, earlier onset due to concentrated risk factors
Risk FactorsShifting diets, reduced physical labour, tobacco/alcohol useSedentary lifestyles, UPF consumption, stress, pollution
Healthcare AccessLimited access to screening, diagnosis, and specialized careBetter access, but often high out-of-pocket expenditure
AwarenessLower awareness of NCD risks and managementGenerally higher awareness, but often reactive rather than preventive

Case Study

Kerala's Epidemiological Transition: Kerala stands out in India with health profiles similar to developed countries, dominated by degenerative diseases (echap11.pdf, 11.41). This advanced stage of epidemiological transition means that while infectious diseases are largely controlled, the state faces a high burden of NCDs like cardiovascular diseases, diabetes, and cancers. This scenario presents a model for other states to anticipate and prepare for, highlighting the need for robust NCD prevention and management strategies, including early screening, lifestyle interventions, and comprehensive chronic disease care, especially for the elderly population.

Mains Hooks

  • Governance and Public Policy: The NCD challenge necessitates a 'whole-of-government' and 'whole-of-society' approach. This includes inter-ministerial coordination (e.g., Health, Agriculture, Food Processing, Urban Development), strengthening primary healthcare through initiatives like Ayushman Bharat Health and Wellness Centres (HWCs) for screening and early detection, and effective implementation of national programmes like NPCDCS. The role of states in programme implementation is critical (echap11.pdf, 11.56).
  • Ethics: NCDs raise ethical questions about health equity, the right to health, and corporate responsibility. Should the state regulate the marketing of UPFs, sugar, and tobacco? How can healthcare be made affordable and accessible to all, especially for chronic conditions requiring long-term care? The ethical imperative to protect vulnerable populations from NCD risks is paramount.
  • Economy: NCDs impose a significant economic burden through healthcare costs, lost productivity, and premature deaths. Investing in NCD prevention and control is an economic imperative, not just a health one, to safeguard India's demographic dividend and ensure sustainable development. The Economic Survey 2025-26 highlights the importance of dietary reforms as a public health priority (echap11.pdf, 11.62).
  • International Relations: India's NCD burden impacts its ability to achieve Sustainable Development Goal 3 (Good Health and Well-being), particularly target 3.4 to reduce premature mortality from NCDs by one-third by 2030. India's experience can also offer lessons for other developing nations facing similar epidemiological transitions.

Recent Developments

  • Ayushman Bharat: The flagship scheme, particularly its Health and Wellness Centres (HWCs) component, aims to provide comprehensive primary healthcare, including screening and management of common NCDs like hypertension, diabetes, and certain cancers. This is a crucial step towards universal health coverage and preventive care.
  • Eat Right India Movement: Spearheaded by FSSAI, this initiative promotes healthy eating habits, food safety, and sustainable food systems. It aligns with the ICMR-NIN guidelines (echap11.pdf, 11.62) to address dietary risk factors for NCDs, encouraging reduced consumption of salt, sugar, and fat.
  • Fit India Movement: Launched in 2019, this nationwide movement aims to encourage people to inculcate physical activity and sports in their daily lives, directly combating sedentary lifestyles, a major NCD risk factor.
  • Digital Health Initiatives: The Ayushman Bharat Digital Mission (ABDM) aims to create a digital health ecosystem, including electronic health records, which can significantly improve NCD surveillance, diagnosis, and continuity of care.
  • Global Research & Development: The announcement of Russia's cancer vaccine at the Eastern Economic Forum, targeting colorectal cancer and showing promising tumor reduction (60-80%), highlights ongoing global efforts in NCD treatment and prevention, which India can potentially leverage through international collaborations.
Depth 0/5
Start Lesson

The Indian Ministry of Health launched the 'Red Line' campaign to tackle AMR. Many antibiotic medicine strips now feature a vertical red line. This line tells the consumer that the medicine should not be taken without a valid doctor's prescription.

The Indian Ministry of Health launched the 'Red Line' campaign to tackle AMR. Many antibiotic medicine strips now feature a vertical red line. This line tells the consumer that the medicine should not be taken without a valid doctor's prescription. It also warns against 'self-medication,' where people buy medicines based on their own judgment. This visual aid is crucial for a country with high rates of self-prescribing.

Depth 0/5
Start Lesson

This is a traditional method of making vaccines. Scientists take the harmful virus or bacteria and 'inactivate' or kill it using heat, radiation, or chemicals. Since the pathogen is dead, it cannot multiply or cause illness in the body.

This is a traditional method of making vaccines. Scientists take the harmful virus or bacteria and 'inactivate' or kill it using heat, radiation, or chemicals. Since the pathogen is dead, it cannot multiply or cause illness in the body. However, the body still recognizes the outer shape of the germ and learns to fight it. Example: Covaxin (by Bharat Biotech) and the Polio vaccine (Salk vaccine).

Depth 0/5
Start Lesson

Vaccine platforms are the technologies used to create a vaccine. Inactivated vaccines use a killed version of the germ (e.g., COVAXIN). Viral vector vaccines use a different, safe virus to deliver instructions to cells (e.g., Covishield).

Vaccine platforms are the technologies used to create a vaccine. Inactivated vaccines use a killed version of the germ (e.g., COVAXIN). Viral vector vaccines use a different, safe virus to deliver instructions to cells (e.g., Covishield). mRNA vaccines use a piece of genetic code to teach cells how to make a protein that triggers an immune response. Knowing these differences is crucial for modern science questions.

Depth 0/5
Start Lesson

A vaccine platform is the basic technology used to create a vaccine. For example, 'Inactivated' vaccines use a dead version of the germ to trigger an immune response.

A vaccine platform is the basic technology used to create a vaccine. For example, 'Inactivated' vaccines use a dead version of the germ to trigger an immune response. 'Viral Vector' vaccines use a different, harmless virus to deliver instructions to our cells. 'mRNA' vaccines use a tiny piece of genetic code to teach cells how to make a protein that triggers the immune system. Example: Covaxin is an inactivated vaccine.

Depth 0/5
Start Lesson

ACE2 is a protein found on the surface of many cell types, especially in the lungs. It normally helps regulate blood pressure. The SARS-CoV-2 virus uses its spike protein to bind to ACE2 like a key in a lock.

ACE2 is a protein found on the surface of many cell types, especially in the lungs. It normally helps regulate blood pressure. The SARS-CoV-2 virus uses its spike protein to bind to ACE2 like a key in a lock. This allows the virus to enter and infect the cell. Because many ACE2 receptors are in the lungs, the virus causes severe breathing issues. Example: If ACE2 is the door lock, the virus spike is the master key.

Depth 0/5
Start Lesson

AMR occurs when bacteria develop the ability to defeat the drugs designed to kill them. This happens through natural selection and genetic mutations. When people stop their medication early, the 'superbugs' survive and multiply.

AMR occurs when bacteria develop the ability to defeat the drugs designed to kill them. This happens through natural selection and genetic mutations. When people stop their medication early, the 'superbugs' survive and multiply. For example, Multi-Drug Resistant Tuberculosis (MDR-TB) is a major health concern in India where standard treatments no longer work effectively. This requires longer and more expensive treatments with more side effects.

Depth 0/5
Start Lesson

A biofilm is a community of microorganisms that stick to a surface and to each other. They create a protective slimy layer. This layer makes them up to 1,000 times more resistant to antibiotics than single bacteria.

A biofilm is a community of microorganisms that stick to a surface and to each other. They create a protective slimy layer. This layer makes them up to 1,000 times more resistant to antibiotics than single bacteria. They commonly form on medical devices like heart valves or catheters. They also form on food pipes, leading to food safety issues. This was a direct question in the 2022 Prelims.

Depth 0/5
Start Lesson

Biofilms are protective layers or 'slimes' created by groups of bacteria. They stick to surfaces like medical heart valves, catheters, or even teeth.

Biofilms are protective layers or 'slimes' created by groups of bacteria. They stick to surfaces like medical heart valves, catheters, or even teeth. This layer acts as a shield, making it up to 1,000 times harder for antibiotics or the body's immune system to reach the bacteria inside. Biofilms are a major cause of chronic infections in hospitals and are a key factor in how bacteria survive drug treatments.

Depth 0/5
Start Lesson

A biofilm is a sticky layer of slime created by groups of bacteria to protect themselves from the environment. These can form on medical implants like heart valves or food processing surfaces.

A biofilm is a sticky layer of slime created by groups of bacteria to protect themselves from the environment. These can form on medical implants like heart valves or food processing surfaces. Biofilms act as a physical shield, making it up to 1,000 times harder for antibiotics to reach and kill the bacteria inside. This is a common reason why chronic infections are so difficult to treat with standard medicine.

Depth 0/5
Start Lesson

The World Health Organization (WHO) created the AWaRe tool to help doctors use antibiotics wisely. It divides drugs into three categories. 'Access' drugs are for common infections and should be widely available.

The World Health Organization (WHO) created the AWaRe tool to help doctors use antibiotics wisely. It divides drugs into three categories. 'Access' drugs are for common infections and should be widely available. 'Watch' drugs are for specific, serious infections and have a higher risk of causing resistance. 'Reserve' drugs are 'last-resort' options used only when all other medicines fail. For example, Colistin is a reserve drug used for life-threatening infections caused by multi-drug resistant bacteria.

Depth 0/5
Start Lesson

Biofilms are groups of microorganisms like bacteria that stick to each other and to surfaces. They create a slimy layer for protection. Biofilms are dangerous because they can form on medical implants like heart valves.

Biofilms are groups of microorganisms like bacteria that stick to each other and to surfaces. They create a slimy layer for protection. Biofilms are dangerous because they can form on medical implants like heart valves. They are very hard to kill because the slimy layer protects the bacteria from antibiotics. Example: Dental plaque on teeth is a type of biofilm.

Depth 0/5
Start Lesson

A vaccine platform is the basic technology used to create a vaccine. Inactivated vaccines (Covaxin) use a dead virus. Viral vector vaccines (Covishield) use a modified harmless virus to carry messages.

A vaccine platform is the basic technology used to create a vaccine. Inactivated vaccines (Covaxin) use a dead virus. Viral vector vaccines (Covishield) use a modified harmless virus to carry messages. mRNA vaccines (Pfizer) use genetic code to trigger an immune response. Knowing these differences is crucial because each technology has different storage and production needs. Example: Covaxin uses a killed version of SARS-CoV-2 itself.

Depth 0/5
Start Lesson

These are diseases transmitted by vectors, which are living carriers. The most common vectors are mosquitoes, ticks, and flies. These organisms do not cause the disease themselves but carry the pathogen from an infected person to a healthy one.

These are diseases transmitted by vectors, which are living carriers. The most common vectors are mosquitoes, ticks, and flies. These organisms do not cause the disease themselves but carry the pathogen from an infected person to a healthy one. Example: The Anopheles mosquito carries the Plasmodium parasite, which causes Malaria in humans.

Depth 0/5
Start Lesson

mRNA stands for 'messenger RNA'. Unlike traditional vaccines, mRNA vaccines do not use any part of the actual virus. Instead, they carry a genetic code that acts like a message for our cells.

mRNA stands for 'messenger RNA'. Unlike traditional vaccines, mRNA vaccines do not use any part of the actual virus. Instead, they carry a genetic code that acts like a message for our cells. This message tells the cells to build a harmless 'spike protein' similar to the one on the virus. The immune system sees this protein, realizes it does not belong there, and creates antibodies. Example: The Pfizer-BioNTech and Moderna COVID-19 vaccines.

Depth 0/5
Start Lesson

This platform uses a safe virus (the 'vector') to deliver genetic material from the harmful virus into the human body. Think of it like a 'Trojan Horse'. The carrier virus (often an Adenovirus) is modified so it cannot cause disease.

This platform uses a safe virus (the 'vector') to deliver genetic material from the harmful virus into the human body. Think of it like a 'Trojan Horse'. The carrier virus (often an Adenovirus) is modified so it cannot cause disease. It carries the 'blueprints' of the target virus into the cell so the body can learn to recognize it. Example: Covishield (uses a Chimpanzee Adenovirus) and Sputnik V.

Depth 0/5
Start Lesson

Inactivated vaccines use a version of the germ that has been killed using chemicals, heat, or radiation. Since the germ is dead, it cannot cause the disease or replicate inside the body.

Inactivated vaccines use a version of the germ that has been killed using chemicals, heat, or radiation. Since the germ is dead, it cannot cause the disease or replicate inside the body. However, the immune system can still recognize the dead germ and learn how to fight it. These vaccines often require multiple doses or 'booster shots' to provide long-term protection. A famous Indian example is Covaxin, developed by Bharat Biotech for COVID-19.

Depth 0/5
Start Lesson

This is a new and advanced technology. Instead of using a real germ, mRNA vaccines give our cells a 'genetic instruction manual'. This manual tells our cells how to make a harmless piece of the 'spike protein' found on the virus.

This is a new and advanced technology. Instead of using a real germ, mRNA vaccines give our cells a 'genetic instruction manual'. This manual tells our cells how to make a harmless piece of the 'spike protein' found on the virus. Once the protein is made, the immune system treats it as an intruder and creates antibodies. The mRNA itself is destroyed by the body shortly after. Examples include the Pfizer and Moderna COVID-19 vaccines.

Depth 0/5
Start Lesson

Communicable diseases (Infectious) are caused by external germs and can spread (e.g., Flu, TB). Non-communicable diseases (NCDs) are caused by internal factors like poor diet, lack of exercise, or genetics (e.g., Hypertension, Diabetes).

Communicable diseases (Infectious) are caused by external germs and can spread (e.g., Flu, TB). Non-communicable diseases (NCDs) are caused by internal factors like poor diet, lack of exercise, or genetics (e.g., Hypertension, Diabetes). NCDs are now the leading cause of death globally. India has a national program specifically to control NCDs at the primary health level.

Depth 0/5
Start Lesson

RT-PCR stands for Reverse Transcription Polymerase Chain Reaction. It is a laboratory technique used to detect the virus's RNA. Since the virus has RNA and humans have DNA, the test first converts viral RNA into DNA.

RT-PCR stands for Reverse Transcription Polymerase Chain Reaction. It is a laboratory technique used to detect the virus's RNA. Since the virus has RNA and humans have DNA, the test first converts viral RNA into DNA. Then, it makes millions of copies of that DNA to see if the virus is present. It is considered the 'Gold Standard' because it is highly accurate. Example: It acts like a biological photocopier to find a specific page of text.

Depth 0/5
Start Lesson

Broad-spectrum antibiotics are like a 'wide net' that kills many different types of bacteria, both good and bad. Doctors use them when the exact cause of infection is unknown.

Broad-spectrum antibiotics are like a 'wide net' that kills many different types of bacteria, both good and bad. Doctors use them when the exact cause of infection is unknown. Narrow-spectrum antibiotics are like a 'sniper' that targets only one specific group of bacteria. For example, Penicillin G is a narrow-spectrum drug, while Tetracycline is broad-spectrum. Using narrow-spectrum drugs helps preserve the healthy bacteria in our bodies.

Depth 0/5
Start Lesson

These vaccines use a different, harmless virus (the vector) to carry a message into our cells. This 'vector' acts like a delivery truck. Inside the truck is the genetic code of the actual disease-causing virus.

These vaccines use a different, harmless virus (the vector) to carry a message into our cells. This 'vector' acts like a delivery truck. Inside the truck is the genetic code of the actual disease-causing virus. Once inside the body, it tells our cells to produce a specific protein that triggers an immune response. It does not cause the disease. Covishield (Oxford-AstraZeneca) and the Russian Sputnik V are major examples of this technology.

Depth 0/5
Start Lesson

Ready to practice? Start an interactive lesson.

Start Lesson: Non-Communicable & Lifestyle Diseases